Artemov, D.; Mori, N.; Okollie, B.; Bhujwalla, Z. M. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles, Magn. Reson. Med. 2003, 49, 403-408.
Bulte, J.W. M.; Modo, M. M. J. Nanoparticles in Biomedical Imaging, Emerging Technologies and Applications. Springer: New York, 2007.
Modo, M.; Hoehn, M.; Bulte, J. W. Cellular MR imaging, Mol. Imaging 2005, 4, 143-164.
Hopkins, C. R.; Trowbridge, I. S. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J. Cell Biol. 1983, 97, 508-521.
Kresse, M.; Wagner, S.; Pfefferer, D.; Lawaczeck, R.; Elste, V.; Semmler, W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn. Reson. Med. 1998, 40, 236-242.
Bulte, J.W.; Zhang, S.; van Gelderen, P.; Herynek, V.; Jordan, E. K.; Duncan, I. D.; Frank, J. A. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc.Natl. Acad. Sci.U.S.A. 1999, 96, 15256-15261.
Weissleder, R.; Moore, A.;Mahmood, U.; Bhorade, R.; Benveniste, H.; Chiocca, E. A.; Basilion, J. P. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 2000, 6, 351-355.
Deans, A. E.; Wadghiri, Y. Z.; Bernas, L. M.; Yu, X.; Rutt, B. K.; Turnbull, D. H. Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn. Reson. Med. 2006, 56, 51-59.
Harrison, P. M.; Arosio, P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1996, 1275, 161-203.
Treffry, A.; Zhao, Z.; Quail, M. A.; Guest, J. R.; Harrison, P. M. Dinuclear center of ferritin: studies of iron binding and oxidation show differences in the two iron sites. Biochemistry. 1997, 36, 432-441.
Cohen, B.; Dafni, H.; Meir, G.; Harmelin, A.; Neeman, M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia. 2005, 7, 109-117.
Wang, Z. J.; Boddington, S.; Wendland, M.; Meier, R.; Corot, C.; Daldrup-Link, H. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr. Radiol. 2008, 38, 529-537.
Sun, C.; Veiseh, O.; Gunn, J.; Fang, C.; Hansen, S.; Lee, D.; Sze, R.; Ellenbogen, R. G.; Olson, J.; Zhang, M. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4, 372-379.
Serda, R. E.; Adolphi, N. L.; Bisoffi, M.; Sillerud, L. O. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol. Imaging 2007, 6, 277-288.
Yang, L.; Mao, H.; Wang, Y. A.; Cao, Z.; Peng, X.; Wang, X.; Duan, H.; Ni, C.; Yuan, Q.; Adams, G.; Smith, M. Q.; Wood, W. C.; Gao, X.; Nie, S. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 2009, 5, 235-243.
Leuschner, C.; Kumar, C. S.; Hansel,W.; Soboyejo,W.; Zhou, J.; Hormes, J. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res. Treat. 2006, 99, 163-176.
Anderson, S. A.; Glod, J.; Arbab, A. S.; Noel, M.; Ashari, P.; Fine, H. A.; Frank, J. A. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005, 105, 420-425.
Moore, A.;Weissleder, R.; Bogdanov, A. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J. Magn. Reson. Imaging 1997, 7, 1140-1145.
Moore, A.;Marecos, E.; Bogdanov, A.;Weissleder, R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000, 214, 568-574.
Modo, M.; Cash, D.;Mellodew, K.;Williams, S. C.; Fraser, S. E.; Meade, T. J.; Price, J.; Hodges, H. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002, 17, 803-811.
Crich, S. G.; Biancone, L.; Cantaluppi, V.; Duo, D.; Esposito, G.; Russo, S.; Camussi, G.; Aimé, S. Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn. Reson. Med. Engl. 2004, 51, 938-944.
Aimé, S.; Carrera, C.; Delli Castelli, D.; Crich, S. G.; Terreno, E. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew. Chem. Int. Ed. 2005, 44, 1813-1815.
Rudelius, M.; Daldrup-Link, H. E.; Heinzmann, U.; Piontek, G.; Settles, M.; Link, T. M.; Schlegel, J. Highly efficient paramagnetic labelling of embryonic and neuronal stem cells. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1038-1044.
Schoepf, U.; Mercos, E. M.; Melder, R. J.; Jain, R. K.; Weissleder, R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998, 24, 642-646, 648-651.
Yeh, T. C.; Zhang, W.; Ildstad, S. T.; Ho, C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn. Reson. Med. 1993, 30, 617-625.
Jendelova, P.; Herynek, V.; DeCroos, J.; Glogarova, K.; Andersson, B.; Hajek, M.; Sykova, E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn. Reson. Med. 2003, 50, 767-776.
Jendelova, P.; Herynek,V.;Urdzikova, L.; Glogarova, K.;Kroupova, J.; Andersson, B.;Bryja,V.; Burian, M.; Hajek, M.; Sykova, E. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 2004, 76, 232-243.
Sykova, E.; Jendelova, P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann. N.Y. Acad. Sci. 2005, 1049, 146-160.
Daldrup-Link, H. E.; Rudelius, M.; Oostendorp, R. A.; Settles, M.; Piontek, G.; Metz, S.; Rosenbrock, H.; Keller, U.; Heinzmann, U.; Rummeny, E. J.; Schlegel, J.; Link, T. M. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003, 228, 760-767.
Mailänder, V.; Lorenz, M. R.; Holzapfel, V.; Musyanovych, A.; Fuchs, K.; Wiesneth, M.; Walther, P.; Landfester, K.; Schrezenmeier, H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol. Imaging Biol. 2008, 10, 138-146.
Kalish, H.; Arbab, A. S.; Miller, B. R.; Lewis, B. K.; Zywicke, H. A.; Bulte, J. W.; Bryant, L. H., Jr; Frank, J. A. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. 2003, 50, 275-282.
Bulte, J.W.Magnetic nanoparticles as markers for cellularMR imaging. J. Magn. Magn. Mater. 2005, 289, 423-427.
Frank, J. A.; Miller, B. R.; Arbab, A. S.; Zywicke, H. A.; Jordan, E. K.; Lewis, B. K.; Bryant, L. H.; Bulte, J. W. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228, 480-487.
Arbab, A. S.; Yocum, G. T.; Wilson, L. B.; Parwana, A.; Jordan, E. K.; Kalish, H.; Frank, J. A. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol. Imaging 2004, 3, 24-32.
Arbab, A. S.; Yocum, G. T.; Kalish, H.; Jordan, E. K.; Anderson, S. A.; Khakoo, A. Y.; Read, E. J.; Frank, J. A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104, 1217-1223.
Superfect® Transfection Reagent Handbook, For High Transfection Efficiencies in a Broad Range of Cell Lines. Qiagen Valencia, CA, 2000.
Bulte, J. W.; Douglas, T.; Witwer, B.; Zhang, S. C.; Strable, E.; Lewis, B. K.; Zywicke, H.; Miller, B.; van Gelderen, P.; Moskowitz, B.M.; Duncan, I. D.; Frank, J. A. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001, 19, 1141-1147.
Klajnert, B.; Bryszewska, M. Dendrimers: properties and applications. Acta. Biochim. Pol. 2001, 48, 199-208.
Wilhelm, C.; Billotey, C.; Roger, J.; Pons, J. N.; Bacri, J. C.; Gazeau, F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003, 24, 1001-1011.
Boutry, S.; Brunin, S.;Mahieu, I.; Laurent, S.; Vander Elst, L.;Muller, R. N. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. Contrast Media Mol. Imaging 2008, 3, 223-232.
Wrobel, I.; Collins, D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta 1995, 1235, 296-304.
Hoehn, M.; Kustermann, E.; Blunk, J.; Wiedermann, D.; Trapp, T.; Wecker, S.; Focking, M.; Arnold, H.;Hescheler, J.; Fleischmann, B. K.; Schwindt,W.; Buhrle,C.Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16267-16272.
van den Bos, E. J.; Wagner, A.; Mahrholdt, H.; Thompson, R. B.; Morimoto, Y.; Sutton, B. S.; Judd, R. M.; Taylor, D. A. Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant. 2003, 12, 743-756.
Vives, E.; Brodin, P.; Lebleu, B. Atruncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997, 272, 16010-16017.
Potocky, T. B.;Menon, A. K.; Gellman, S.H. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 2003, 278, 50188-50194.
Vives, E.; Richard, J. P.; Rispal, G.; Lebleu, B. TAT peptide internalization: seeking the mechanism of entry. Curr. Protein. Pept. Sci. 2003, 4, 125-132.
Bhorade, R.;Weissleder, R.; Nakakoshi, T.;Moore, A.; Tung, C. H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug. Chem. 2000, 11, 301-305.
Prantner, A. M.; Sharma, V.; Garbow, J. R.; Piwnica-Worms, D. Synthesis and characterization of a Gd-DOTA-D-permeation peptide for magnetic resonance relaxation enhancement of intracellular targets. Mol. Imaging 2003, 2, 333-341.
Lewin, M.; Carlesso, N.; Tung, C. H.; Tang, X.W.; Cory, D.; Scadden, D. T.;Weissleder, R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000, 18, 410-414.
Josephson, L.; Tung, C. H.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 1999, 10, 186-191.
Tung, C. H.;Weissleder, R. Arginine containing peptides as delivery vectors. Adv. Drug. Deliv. Rev. 2003, 55, 281-294.
Walczak, P.; Kedziorek, D. A.; Gilad, A. A.; Lin, S.; Bulte, J. W. Instant MR labeling of stem cells using magnetoelectroporation. Magn. Reson. Med. 2005, 54, 769-774.
Hinds, K. A.; Hill, J. M.; Shapiro, E.M.; Laukkanen, M. O.; Silva, A. C.; Combs, C. A.; Varnet, T. R.; Balaban, R. S.; Koretsky, A. P.; Dunbar, C. E. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003, 102, 867-872.
Shapiro, E. M.; Skrtic, S.; Koretsky, A. P. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn. Reson. Med. 2005, 53, 329-338.
Weisskoff, R. M.; Zuo, C. S.; Boxerman, J. L.; Rosen, B. R. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn. Reson. Med. 1994, 31, 601-610.
Shapiro, E. M.; Skrtic, S.; Sharer, K.; Hill, J. M.; Dunbar, C. E.; Koretsky, A. P. MRI detection of single particles for cellular imaging. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 10901-10906.
Shapiro, E. M.; Sharer, K.; Skrtic, S.; Koretsky, A. P. In vivo detection of single cells by MRI. Magn. Reson. Med. 2006, 55, 242-249.
Raynal, I.; Prigent, P.; Peyramaure, S.; Najid,A.; Rebuzzi,C.; Corot, C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 2004, 39, 56-63.
Palecanda, A.; Paulauskis, J.; Al-Mutairi, E.; Imrich, A.; Qin, G.; Suzuki, H.; Kodama, T.; Tryggvason, K.; Koziel, H.; Kobzik, L. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J. Exp. Med. 1999, 189, 1497-1506.
Fleige, G.; Seeberger, F.; Laux, D.; Kresse, M.; Taupitz, M.; Pilgrimm, H.; Zimmer, C. In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Invest. Radiol. 2002, 37, 482-488.
Champion, J. A.; Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 4930-4934.
Jelezarova, E.; Luginbuehl, A.; Lutz, H. U. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation. J. Biol. Chem. 2003, 278, 51806-51812.
Ahrens, E. T.; Feili-Hariri,M.; Xu, H.; Genove, G.; Morel, P. A. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn. Reson. Med. 2003, 49, 1006-1013.
Himmelreich, U.; Aimé, S.; Hyeronymus, T.; Justicia, C.; Uggeri, F.; Zenke, M.; Hoehn, M. A responsive MRI contrast agent to monitor functional cell status. Neuroimage 2006, 32, 1142-1149.
Kostura, L.; Kraitchman, D. L.; Mackay, A. M.; Pittenger, M. F.; Bulte, J. W. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004, 17, 513-517.
Arbab, A. S.; Bashaw, L. A.; Miller, B. R.; Jordan, E. K.; Bulte, J. W.; Frank, J. A. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003, 76, 1123-1130.
Stroh, A.; Zimmer, C.;Gutzeit, C.; Jackstadt, M.;Marschinke, F.; Jung, T.; Pilgrimm, H.;Grune, T. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic. Biol. Med. 2004, 36, 976-984.
Neri, M.; Maderna, C.; Cavazzin, C.; Deidda-Vigoriti, V.; Politi, L. S.; Scotti, G.; Marzola, P.; Sbarbati, A.; Vescovi, A.L.; Gritti, A. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem. Cells 2008, 26, 505-516.
Smirnov, P.; Gazeau, F.; Lewin, M.; Bacri, J. C.; Siauve, N.; Vayssettes, C.; Cuenod, C. A.; Clement, O. In vivo cellular imaging of magnetically labeled hybridomas in the spleen with a 1.5-T clinical MRI system. Magn. Reson. Med. 2004, 52, 73-79.
Daldrup-Link, H. E.; Rudelius, M.; Piontek, G.; Metz, S.; Brauer, R.; Debus, G.; Corot, C.; Schlegel, J.; Link, T. M.; Peschel, C.; Rummeny, E. J.; Oostendorp, R. A. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005, 234, 197-205.
Anderson, S. A.; Shukaliak-Quandt, J.; Jordan, E. K.; Arbab, A. S.; Martin, R.; McFarland, H.; Frank, J. A. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 2004, 55, 654-659.
Kircher, M. F.;Allport, J. R.;Graves, E. E.; Love,V.; Josephson, L.; Lichtman, A. H.;Weissleder, R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003, 63, 6838-6846.
Smirnov, P.; Lavergne, E.; Gazeau, F.; Lewin, M.; Boissonnas, A.; Doan, B. T.; Gillet, B.; Combardière, C.; Clément, O. In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn. Reson. Med. 2006, 56, 498-508.
Daldrup-Link, H. E.; Meier, R.; Rudelius, M.; Piontek, G.; Piert, M.; Metz, S.; Settles, M.; Uherek, C.; Wels, W.; Schlegel, J.; Rummeny, E. J. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur. Radiol. 2005, 15, 4-13.
de Vries, I. J.; Lesterhuis, W. J.; Barentsz, J. O.; Verdijk, P.; van Krieken, J. H.; Boerman, O. C.; Oyen, W. J.; Bonenkamp, J. J.; Boezeman, J. B.; Adema, G. J.; Bulte, J.W.; Scheenen, T. W.; Punt, C. J.; Heerschap, A.; Figdor, C. G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005, 23, 1407-1413.
Modo, M.; Mellowdew, K.; Cash, D.; Fraser, S. E.; Meade, T. J.; Price, J.; Williams, S. C. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 2004, 21, 311-317.
Zhang, Z.; Jiang, Q.; Jiang, F.; Ding, G.; Zhang, R.; Wang, L.; Zhang, L.; Robin, A. M.; Katakowski, M.; Chopp, M. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 2004, 23, 281-287.
Hill, J. M.; Dick, A. J.; Raman, V. K.; Thompson, R. B.; Yu, Z. X.; Hinds, K. A.; Pessanha, B. S.; Guttman, M. A.; Varney, T. R.; Martin, B. J.; Dunbar, C. E.; McVeigh, E. R.; Lederman, R. J. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003, 108, 1009-1014.
Kraitchman, D. L.; Heldman, A. W.; Atalar, E.; Amado, L. C.; Martin, B. J.; Pittenger, M. F.; Hare, J. M.; Bulte, J. W. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107, 2290-2293.
Garot, J.; Unterseeh, T.; Teiger, E.; Champagne, S.; Chazaud, B.; Gherardi, R.; Hittinger, L.; Gueret, P.; Rahmouni, A. Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J. Am. Coll. Cardiol. 2003, 41, 1841-1846.
Rivière, C.; Boudghene, F. P.; Gazeau, F.; Roger, J.; Pons, J. N.; Laissy, J. P.; Allaire, E.; Michel, J. B.; Letourneur, D.; Deux, J. F. Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation. Radiology 2005, 235, 959-967.
Tallheden, T.; Nanmark, U.; Lorentzon, M.; Rakotonirainy, O.; Soussi, B.;Waagstein, F.; Jeppsson, A.; Sjogren-Jansson, E.; Lindhal, A.; Omerovic, E. In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci. 2006, 79, 999-1006.
Kustermann, E.; Roell, W.; Breitbach, M.; Wecker, S.; Wiedermann, D.; Buehrlr, C.; Welz, A.; Hescheler, J.; Fleischmann, B. K.; Hoehn, M. Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed. 2005, 18, 362-370.
Bos, C.; Delmas,Y.; Desmouliere,A.; Solanilla,A.; Hauger, O.;Grosset,C.; Dubus, I.; Ivanovic, Z.; Rosenbaum, J.; Charbord, P.; Combe, C.; Bulte, J. W.; Moonen, C. T.; Ripoche, J.; Grenier, N. In vivoMRimaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004, 233, 781-789.
Hauger, O.; Frost, E. E.; van Heeswijk, R.; Deminiere, C.; Xue, R.; Delmas, Y.; Combe, C.; Moonen, C. T.;Grenier,N.; Bulte, J.W.MRevaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 2006, 238, 200-210.
Jirak, D.; Kriz, J.; Herynek, V.; Andersson, B.; Girman, P.; Burian, M.; Saudek, F.; Hajek, M. MRI of transplanted pancreatic islets. Magn. Reson. Med. 2004, 52, 1228-1233.
Dousset, V.; Doche, B.; Petry, K. G.; Brochet, B.; Delalande, C.; Caille, J. M. Correlation between clinical status and macrophage activity imaging in the central nervous system of rats. Acad. Radiol. 2002, 9 (Suppl 1), S156-S159.
Rausch, M.; Sauter, A.; Frohlich, J.; Neubacher, U.; Radu, E. W.; Rudin, M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn. Reson. Med. 2001, 46, 1018-1022.
Schroeter, M.; Saleh, A.; Wiedermann, D.; Hoehn, M.; Jander, S. Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia. Magn. Reson. Med. 2004, 52, 403-406.
Saleh, A.; Schroeter, M.; Jonkmanns, C.; Hartung, H. P.; Modder, U.; Jander, S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain 2004, 127, 1670-1677.
Hauger, O.; Delalande, C.; Trillaud, H.; Deminiere, C.; Quesson, B.; Kahn, H.; Cambar, J.; Combe, C.; Grenier, N. MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn. Reson. Med. 1999, 41, 156-162.
Beckmann, N.; Cannet, C.; Fringeli-Tanner, M.; Baumann, D.; Pally, C.; Bruns, C.; Zerwes, H. G.; Andriambeloson, E.; Bigaud, M. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn. Reson. Med. 2003, 49, 459-467.
Weinmann, H. J.; Ebert, W.; Misselwitz, B.; Schmitt-Willich, H. Tissue-specific MR contrast agents. Eur. J. Radiol. 2003, 46, 33-44.
Ruehm, S. G.; Corot, C.; Vogt, P.; Kolb, S.; Debatin, J. F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001, 103, 415-422.
Kooi, M. E.; Cappendijk, V. C.; Cleutjens, K. B.; Kessels, A. G.; Kitslaar, P. J.; Borgers, M.; Frederik, P. M.; Daemen, M. J.; van Engelshoven, J. M. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107, 2453-2458.
Wu, Y. L.; Ye, Q.; Foley, L. M.; Hitchens, T. K.; Sato, K.;Williams, J. B.; Ho, C. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 1852-1857.
Zimmer, C.; Wright, S. C., Jr; Engelhardt, R. T.; Johnson, G. A.; Kramm, C.; Breakefield, X. O.;Weissleder, R. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp. Neurol. 1997, 143, 61-69.
Muldoon, L. L.; Sandor, M.; Pinkston, K. E.; Neuwelt, E. A. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 2005, 57, 785-796.
Brillet, P. Y.; Gazeau, F.; Luciani, A.; Bessoud, B.; Cuenod, C. A.; Siauve, N.; Pons, J. N.; Poupon, J.; Clément, O. Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles. Eur. Radiol. 2005, 15, 1369-1377.
Fortin-Ripoche, J. P.; Martina, M. S.; Gazeau, F.; Menager, C.; Wilhelm, C.; Bacri, J. C.; Lesieur, S.; Clément, O. Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. Radiology 2006, 239, 415-424.
Artemov, D.; Bhujwalla, Z. M.; Bulte, J. W. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr. Pharm. Biotechnol. 2004, 5, 485-494.
Hofmann, B.; Bogdanov, A.; Marecos, E.; Ebert, W.; Semmler, W.; Weissleder, R. Mechanism of gadophrin-2 accumulation in tumor necrosis. J. Magn. Reson. Imaging 1999, 9, 336-341.
Bulte, J.W. M.; In vivo MRI cell tracking: clinical studies. AJR. Am. J. Roentgenol. 2009, 193, 3314-3325.
